Get the Stockscreener App
1.32
2.22%
-0.03
Pre-market:
1.33
0.01
+0.76%
Canopy Growth Corporation stock is traded at $1.32, with a volume of 13.28M.
It is down -2.22% in the last 24 hours and down -1.49% over the past month.
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
See More
Previous Close:
$1.35
Open:
$1.36
24h Volume:
13.28M
Relative Volume:
0.56
Market Cap:
$411.83M
Revenue:
$211.87M
Net Income/Loss:
$-551.61M
P/E Ratio:
-0.1934
EPS:
-6.8241
Net Cash Flow:
$-140.45M
1W Performance:
-5.04%
1M Performance:
-1.49%
6M Performance:
-6.38%
1Y Performance:
-75.74%
1-Day Range:
$1.30
$1.36
1-Week Range:
$1.27
$1.40
52-Week Range:
$0.77
$5.80
Canopy Growth Corporation Stock (CGC) Company Profile
Name
Canopy Growth Corporation
Sector
Phone
855-558-9333
Address
1 Hershey Drive, Smiths Falls, ON
Compare CGC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGC
Canopy Growth Corporation
|
1.32 | 421.19M | 211.87M | -551.61M | -140.45M | -6.8241 |
|
ZTS
Zoetis Inc
|
147.53 | 64.68B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.17 | 44.25B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.20 | 41.19B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.61 | 21.74B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
421.04 | 18.93B | 3.08B | 1.24B | 1.07B | 25.61 |
Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-04-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Nov-02-22 | Initiated | Bernstein | Underperform |
| Oct-26-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-08-22 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Mar-22-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-22-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-20-21 | Downgrade | Piper Sandler | Neutral → Underweight |
| Dec-07-21 | Initiated | Wells Fargo | Underweight |
| Nov-18-21 | Initiated | Barclays | Equal Weight |
| Nov-08-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Nov-08-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Nov-08-21 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-01-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-21 | Upgrade | Jefferies | Underperform → Hold |
| Jun-02-21 | Upgrade | Canaccord Genuity | Sell → Hold |
| May-25-21 | Upgrade | MKM Partners | Neutral → Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-24-21 | Downgrade | Jefferies | Hold → Underperform |
| Feb-10-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Feb-10-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-05-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-04-20 | Upgrade | CFRA | Buy → Strong Buy |
| Jun-01-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jun-01-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Jun-01-20 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-01-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-01-20 | Downgrade | Stifel | Buy → Sell |
| May-22-20 | Resumed | BofA/Merrill | Buy |
| Apr-16-20 | Upgrade | Jefferies | Underperform → Hold |
| Jan-28-20 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-19 | Reiterated | Cantor Fitzgerald | Neutral |
| Nov-20-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-15-19 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-14-19 | Downgrade | Seaport Global Securities | Buy → Neutral |
| Oct-11-19 | Downgrade | Jefferies | Hold → Underperform |
| Sep-27-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Sep-18-19 | Initiated | Oppenheimer | Perform |
| Aug-26-19 | Upgrade | Seaport Global Securities | Neutral → Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Buy |
View All
Canopy Growth Corporation Stock (CGC) Latest News
Will Canopy Growth Corporation (11L) stock attract long term capital inflows2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
Is Canopy Growth Corporation meeting your algorithmic filter criteriaFed Meeting & Daily Chart Pattern Signal Reports - newser.com
Will Canopy Growth Corporation stock reach all time highs in 2025IPO Watch & Technical Entry and Exit Tips - newser.com
Will Canopy Growth Corporation stock deliver long term returnsQuarterly Portfolio Review & Smart Money Movement Alerts - Fundação Cultural do Pará
Why Canopy Growth Corporation stock is a must watch in 2025Gap Up & Verified Entry Point Signals - newser.com
Risks Report: Why Canopy Growth Corporation stock is a must watch in 20252025 Price Targets & Verified Swing Trading Watchlists - Fundação Cultural do Pará
Top Cannabis Stocks To ResearchOctober 27th - MarketBeat
Will Canopy Growth Corporation stock continue upward momentumStop Loss & Long-Term Safe Investment Ideas - newser.com
Can Canopy Growth Corporation stock sustain institutional interestJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Is Canopy Growth Corporation stock attractive for ETFs2025 Geopolitical Influence & Long Hold Capital Preservation Plans - newser.com
Measuring Canopy Growth Corporation’s beta against major indicesFed Meeting & Real-Time Chart Pattern Alerts - newser.com
Cannabis Stocks To Watch TodayOctober 23rd - MarketBeat
How Canopy Growth Corporation stock reacts to oil pricesTreasury Yields & Daily Market Momentum Tracking - newser.com
Analyzing Canopy Growth Corporation with risk reward ratio charts2025 Sector Review & Safe Capital Preservation Plans - newser.com
Top Cannabis Stocks To Add to Your WatchlistOctober 24th - MarketBeat
Cannabis Stocks To ConsiderOctober 26th - MarketBeat
Canopy Growth Corporation Stock (CGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.13%
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):